X

Given the current situation, we understand that people may experience worry and even fear about how their disease and treatment may impact their personal risk. Sanofi Genzyme is committed to patient safety and to transparent communication. We are taking COVID-19 seriously, and we are committed to updating the communities we serve with relevant information related to our medicines to help inform health decisions.

As COVID-19 has emerged only recently, there are no available data regarding the impact of the virus on our current therapies. At this time, if you have general questions about our therapies, you should consult the current U.S Prescribing Information (USPI).

Each patient’s situation is unique, and patients and their healthcare providers are in the best position to make decisions regarding their care. In addition to local public health authority guidance, and local guidance from medical or patient associations, more information about COVID-19 can be found on the Centers for Disease Control’s (CDC) website or the World Health Organization’s (WHO) website.

MAT-US-2001107

INDICATION

AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Do not take AUBAGIO if you have severe liver problems, are pregnant or of childbearing potential and not using effective birth control, have had an allergic reaction to AUBAGIO or leflunomide, or are taking a medicine called leflunomide for rheumatoid arthritis. View IMPORTANT SAFETY INFORMATION

How much will I
pay for AUBAGIO?

The amount you pay for AUBAGIO will depend on a number of factors, including:

  • Whether you have prescription drug insurance
  • The type of insurance you have
  • Whether your insurance provider considers the medication to be preferred or not preferred
  • Whether you have met your deductible

Considering these factors, 2 people could pay very different prices for exactly the same prescription.

What is the list
price of AUBAGIO?

All prescription medications have a list price.1 Very few people actually pay the list price, which is a price set by the manufacturer. The list price* of AUBAGIO is $7,668.14 for a 30-day supply, but most people will not pay that price. The amount you pay for AUBAGIO will largely depend on whether you have insurance, the type of insurance you have, whether your insurance provider considers the medication to be preferred or not preferred, and whether you’ve met your deductible.

*List price is also referred to as wholesale acquisition cost or WAC. WAC is the price at which Sanofi sells its products to wholesalers. A monthly supply of AUBAGIO (14 mg or 7 mg) is defined as one 30-pill bottle. List price as of 1/2020.

Which of these options best describes your
insurance situation?

  • Most commercially insured patients pay between $0 and $110.87 per month for AUBAGIO*,2
  • With the AUBAGIO $0 co-pay program, a 1 month supply of AUBAGIO can cost $0
  • Learn more about the AUBAGIO $0 co-pay program

*Out-of-pocket costs were standardized to a 30-day supply period.

Medicare Part D patients can expect to pay an average of $75* per month for AUBAGIO. For patients with co-insurance, the average monthly cost of AUBAGIO may vary.

How much you pay for your prescription drugs may change throughout the year for some people with Part D insurance. You may pay more in the beginning of the year or more later in the year depending on which phase of the Part D benefit you are in.

Some people with Part D coverage are eligible for the Extra Help3 program (also known as the Low-Income Subsidy or "LIS"), and they typically pay $3.60-$8.95 for their prescriptions.4 If you would like to check whether you qualify for this program and apply, please go to www.ssa.gov/benefits/medicare/prescriptionhelp.

If you do not have insurance or are unable to pay for treatment, the Sanofi Genzyme Patient Assistance Program could be the answer. Another solution: an MS One to One Nurse may be able to help you get support from not-for-profit organizations.

Call 1‑855‑676‑63261-855-676-6326 to talk to an MS One to One Nurse for more information and to see if you’re eligible. You may also want to check with your local patient advocacy group about other support.

*Payments are averaged across all phases of Medicare coverage, and include coverage gap and catastrophic phase payments. Out-of-pocket costs were standardized to a 30-day supply period.

Drug coverage under Medicare Part D is divided into four phases: 1) deductible, 2) initial coverage, 3) coverage gap, and 4) catastrophic. Each of these phases has different cost-sharing amounts.

For most people on Medicaid, out-of-pocket costs for prescription drugs like AUBAGIO could range from $4.40-$8.80 per month.5,* To find out if you qualify for Medicaid, or for more information about copays under Medicaid in your state, please go to www.medicaid.gov/state-overviews/index.html.

*Maximum allowable copayments determined by eligible population’s household income.

Some may pay a coinsurance rate as established by the state and FPL level of up to 20% of the state's cost.

If you do not have insurance that covers your prescription medications, or if your insurance does not cover AUBAGIO, you can typically expect to pay the list price shown above plus any additional pharmacy charges. The price you pay varies from pharmacy to pharmacy.

If you do not have insurance or are unable to pay for treatment, the Sanofi Genzyme Patient Assistance Program could be the answer. Another solution: an MS One to One Nurse may be able to help you get support from not-for-profit organizations.

Call 1‑855‑676‑63261-855-676-6326 to talk to an MS One to One Nurse for more information and to see if you’re eligible. You may also want to check with your local patient advocacy group about other support.

References:

  1. Analy$ource
  2. Data on file, Sanofi Genzyme.
  3. Extra Help with Medicare Prescription Drug Plan Costs. https://www.ssa.gov/benefits/medicare/prescriptionhelp. Accessed on February 20, 2019.
  4. Announcement of Calendar Year (CY) 2019 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. Centers for Medicare and Medicare website. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Announcement2019.pdf. Accessed on February 20, 2019.
  5. Medicaid and CHIP overview for assisters. https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf. Accessed on March 6, 2019

INDICATION

AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

IMPORTANT SAFETY INFORMATION

DO NOT TAKE AUBAGIO IF YOU:
  • Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
  • Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1‑800‑745‑4447, option 2.
  • Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1-800-745-4447, option 2.
  • Are of childbearing potential and not using effective birth control.

    It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.

    If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.

  • Have had an allergic reaction to AUBAGIO or a medicine called leflunomide.
  • Take a medicine called leflunomide for rheumatoid arthritis.

AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.

Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vitamins or herbal supplements.

AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; allergic reactions, including serious skin problems; breathing problems (new or worsening); and high blood pressure. Patients with low white blood cell count should not receive certain vaccinations during AUBAGIO treatment and 6 months after.

Tell your doctor if you have any side effect that bothers you or does not go away.

The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.

Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.

Please click here for full Prescribing Information, including boxed WARNING and Medication Guide.

IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO if you have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. View More